Skip to main
University-wide Navigation

Across Kentucky

Biomedical Research

Our Impact

A deserving heart UK HealthCare, Gill Affiliate Network deliver results for transplant patient

It isn’t exactly clear when Ronald Kelly began experiencing heart failure, because he’s always gone to extraordinary lengths to finish what he starts and put on a brave face during difficult times. 

Double the courage Twins born with heart defects define resiliency

Even though 6-year-old Danville twins Lennox and Berkley Frey look the same, they couldn’t be more different.

UK’s Housing Engagement and Research Initiative launches statewide resource hub online

Advancing on the regional and statewide challenge addressing housing needs in the Commonwealth, the University of Kentucky Office of Land-Grant Engagement has launched the Housing Engagement and Research Initiative (HERI) website.

Advancing Kentucky Together: Cardiovascular researcher Ken Campbell

Helping people is at the heart of much of the research conducted at the University of Kentucky. Kenneth S. Campbell, Ph.D., is a professor of both cardiovascular medicine and physiology in the UK College of Medicine. He is also the director of the Gill Cardiovascular Biorepository and the CCTS Biospecimen Core.

College of Pharmacy launches novel bachelor’s degree A gateway to pharmaceutical careers

For the first time in more than 25 years, students can pursue a bachelor’s degree within the nationally ranked University of Kentucky College of Pharmacy. Launching in Fall 2025, the Bachelor of Science in Pharmaceutical Sciences (BSPS) offers an interdisciplinary path to careers in science, research and health care. 

People Behind Our Research Dmitry Strakovsky strives to connect the arts and health

Dmitry “Dima” Strakovsky is fostering collaborations between creative disciplines and health care through an innovative initiative at the University of Kentucky.

Markey home to two breakthrough therapeutic cancer vaccine trials

The same mRNA technology behind COVID-19 vaccines is now being used in the fight against cancer, and the University of Kentucky Markey Cancer Center is among an elite group of institutions offering these promising new treatments through clinical trials